News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Spero Appoints Thomas Parr, Ph.D. As Chief Scientific Officer


5/20/2014 6:58:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies targeting virulence and persistence, for treatment of bacterial infections, today announced that Thomas “Tom” Parr, Ph.D. has joined the company as Chief Scientific Officer. Dr. Parr is a highly regarded microbiologist with more than 25 years of drug discovery experience across both large pharmaceutical and small biotechnology companies. The company also announced its Scientific Advisory Board (SAB).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Spero
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES